FI896289A0 - HAVERHYCLE HETEROCYCLISKA FOERENINGAR. - Google Patents

HAVERHYCLE HETEROCYCLISKA FOERENINGAR.

Info

Publication number
FI896289A0
FI896289A0 FI896289A FI896289A FI896289A0 FI 896289 A0 FI896289 A0 FI 896289A0 FI 896289 A FI896289 A FI 896289A FI 896289 A FI896289 A FI 896289A FI 896289 A0 FI896289 A0 FI 896289A0
Authority
FI
Finland
Prior art keywords
salt
compound
haverhycle
substituted
provides
Prior art date
Application number
FI896289A
Other languages
Finnish (fi)
Other versions
FI102896B1 (en
FI102896B (en
Inventor
Takashi Sohda
Masao Tsuda
Iwao Yamazaki
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI896289A0 publication Critical patent/FI896289A0/en
Priority to FI990541A priority Critical patent/FI990541A/en
Application granted granted Critical
Publication of FI102896B1 publication Critical patent/FI102896B1/en
Publication of FI102896B publication Critical patent/FI102896B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/08—Naphthothiopyrans; Hydrogenated naphthothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4021—Esters of aromatic acids (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
    • C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655381—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
    • C07F9/65539—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Lubricants (AREA)
  • Pretreatment Of Seeds And Plants (AREA)

Abstract

The present invention provides a sulfur-containing heterocyclic compound of general formula (I) <CHEM> wherein ring A is a benzene ring which may be substituted; R is a hydrogen atom or a hydrocarbon group which may be substituted; B is a carboxyl group which may be esterified or amidated; X is -CH(OH)- or -CO-; k is 0 or 1; and k min is 0, 1 or 2 or a salt thereof. Also, it provides a process for producing the compound (I) or a salt thereof and a pharmaceutical preparation for use in the treatment of osteoporosis comprising the compound (I) or salt thereof. The compounds (I) and salts thereof show excellent bone resorption inhibitory activity.
FI896289A 1988-12-28 1989-12-27 Process for the preparation of pharmaceutically active sulfur-containing hot erocyclic compounds FI102896B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI990541A FI990541A (en) 1988-12-28 1999-03-11 Sulfur containing heterocyclic compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP33524088 1988-12-28
JP33524088 1988-12-28
JP30360389 1989-11-21
JP30360389 1989-11-21

Publications (3)

Publication Number Publication Date
FI896289A0 true FI896289A0 (en) 1989-12-27
FI102896B1 FI102896B1 (en) 1999-03-15
FI102896B FI102896B (en) 1999-03-15

Family

ID=26563567

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896289A FI102896B (en) 1988-12-28 1989-12-27 Process for the preparation of pharmaceutically active sulfur-containing hot erocyclic compounds

Country Status (16)

Country Link
US (1) US5071841A (en)
EP (1) EP0376197B1 (en)
JP (1) JP2924033B2 (en)
KR (1) KR0142429B1 (en)
CN (1) CN1032470C (en)
AT (1) ATE112770T1 (en)
AU (1) AU623722B2 (en)
CA (1) CA2006723C (en)
DE (1) DE68918827T2 (en)
DK (1) DK656789A (en)
ES (1) ES2060735T3 (en)
FI (1) FI102896B (en)
HK (1) HK17396A (en)
HU (1) HU209453B (en)
NO (1) NO179977C (en)
NZ (1) NZ231939A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158943A (en) * 1988-11-21 1992-10-27 Takeda Chemical Industries, Ltd. Sulfur-containing heterocyclic compounds
ES2157887T3 (en) * 1990-05-30 2001-09-01 Takeda Chemical Industries Ltd HETEROCICLICAL COMPOUNDS CONTAINING SULFUR.
CA2191980A1 (en) * 1994-07-04 1996-01-18 Takashi Sohda Phosphonic acid compounds, their production and use
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
EP0842179A1 (en) * 1995-07-24 1998-05-20 Takeda Chemical Industries, Ltd. Production of optically active benzothiepin salts
AU3868997A (en) 1996-08-26 1998-03-19 Takeda Chemical Industries Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
EP0930874A2 (en) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. A method for producing a microparticle
WO1998047485A2 (en) * 1997-04-24 1998-10-29 Takeda Chemical Industries, Ltd. Apatite-coated solid composition
WO1999065474A2 (en) * 1998-06-15 1999-12-23 Takeda Chemical Industries, Ltd. Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
AU5194999A (en) 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
TW557298B (en) * 2000-08-14 2003-10-11 Ciba Sc Holding Ag A compound, a photopolymerizible composition, a process for producing coatings and a method for causing a photoinitiator to accumulate at the surface of coatings
WO2002030888A2 (en) * 2000-10-10 2002-04-18 Calyx Therapeutics, Inc. Tricyclic compounds and uses thereof
EP1974754A4 (en) 2006-01-18 2012-09-05 Nat Univ Corp Tokyo Med & Dent Biomaterial for osteogenesis containing osteogenesis promoter and nanogel
TWI476187B (en) * 2008-02-29 2015-03-11 Nissan Chemical Ind Ltd Thiophene compounds and intermediates thereof
TWI594975B (en) 2013-04-24 2017-08-11 第一三共股份有限公司 Compound having di-carboxylic moiety
EP3199529B1 (en) 2014-09-26 2021-01-27 Daiichi Sankyo Company, Limited Salt of dicarboxylic acid compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1935685A1 (en) * 1969-07-10 1971-01-14 Schering Ag New antimicrobial compounds
US3636049A (en) * 1969-11-26 1972-01-18 Pfizer Isothiochroman carboxamides
FR2621038B1 (en) * 1987-09-28 1989-12-29 Rhone Poulenc Sante ALCADIAN DERIVATIVES, THEIR PREPARATIONS, THE MEDICINES CONTAINING THEM, AND INTERMEDIATE PRODUCTS

Also Published As

Publication number Publication date
KR900009624A (en) 1990-07-05
NO895267D0 (en) 1989-12-27
EP0376197A1 (en) 1990-07-04
JPH03232880A (en) 1991-10-16
NZ231939A (en) 1991-07-26
CA2006723C (en) 1998-08-25
CN1045106A (en) 1990-09-05
NO895267L (en) 1990-06-29
HU896790D0 (en) 1990-03-28
ATE112770T1 (en) 1994-10-15
US5071841A (en) 1991-12-10
NO179977C (en) 1997-01-22
FI102896B1 (en) 1999-03-15
EP0376197B1 (en) 1994-10-12
HK17396A (en) 1996-02-09
ES2060735T3 (en) 1994-12-01
KR0142429B1 (en) 1998-06-01
JP2924033B2 (en) 1999-07-26
DE68918827D1 (en) 1994-11-17
CA2006723A1 (en) 1990-06-28
AU4732089A (en) 1990-07-19
AU623722B2 (en) 1992-05-21
DK656789D0 (en) 1989-12-21
DK656789A (en) 1990-06-29
DE68918827T2 (en) 1995-02-16
HU209453B (en) 1994-06-28
CN1032470C (en) 1996-08-07
FI102896B (en) 1999-03-15
NO179977B (en) 1996-10-14

Similar Documents

Publication Publication Date Title
FI896289A0 (en) HAVERHYCLE HETEROCYCLISKA FOERENINGAR.
AU4257889A (en) Sulphonamido-phenylalkanoic acid derivatives having thromboxane A2 antagonist activity
ES2031913T3 (en) A PROCEDURE FOR PREPARING A QUINAZOLINONE DERIVATIVE.
ATE103812T1 (en) COMPOSITION FOR THE TREATMENT OF ISCHEMIC DISORDERS IN ORGANS.
DE69326395D1 (en) Spirooxathiolan quinuclidine derivative for the treatment of Sjogren&#39;s syndrome
DK0460488T3 (en) Sulfur-containing heterocyclic compounds
ATE206926T1 (en) USE OF A PHOSPHORIC ACID DIESTER FOR PRODUCING A MEDICINAL PRODUCT FOR THE TREATMENT OF ACNE
DE69510338D1 (en) AZIRDINE DERIVATIVES, THEIR PRODUCTION AND USE
ATE180669T1 (en) USE OF PREGNANDER DERIVATIVES TO TREAT TUMORS
DE69005984D1 (en) 2-hydroxy-3-phenoxypropylamino compounds.
HU9601701D0 (en) Aromatic hydroxamic acid compounds, process for producing them and their use
DK360388A (en) MEDICINE FOR TREATMENT OF HEART INFFICIENCY
ATE114309T1 (en) N-AZABICYCLO(3.3.0&gt;OCTANAMIDES OF AROMATIC ACIDS.
HU9203052D0 (en) Method for treatment of hypertension
DE69019423D1 (en) Epoxysuccinic acid derivatives useful as specific inhibitors of Cathepsin B.
DE69619088D1 (en) Quinoxaline derivatives used to treat tinnitus
AU4706489A (en) Oxadiazol-azabicycl compounds and their pharmaceutical use
AU2013888A (en) Uricosuric composition

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD.